The persistence of low ADAMTS-13 activity despite clinical and hematological recovery suggests a different pathogenesis and clinical course compared to the autoimmune theory commonly attributed to primary idiopathic TTP. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.